Evolution of Parent-Targeted Interventions for Pain-Predominant Disorders of Gut-Brain Interactions: Research and

Katherine Lamparyk1, Jacklyn Stellway2, Cathleen Turnage2

  • 1Akron Children's Hospital.

Insights

Parent-targeted interventions show promise for childhood functional abdominal pain disorders. Engaging parents and stakeholders is key to integrating these effective strategies into clinical practice for better outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology
  • Behavioral Medicine

Background:

  • Functional abdominal pain-related disorders of gut-brain interactions (DGBIs) in children are complex, influenced by biopsychosocial factors.
  • Parental involvement is increasingly recognized as crucial for managing pediatric DGBIs.
  • Understanding the child's environment is vital for effective treatment.

Purpose of the Study:

  • To review the development of parent-targeted interventions for pediatric pain-related DGBIs.
  • To offer recommendations for implementing these interventions in clinical settings.
  • To bridge the gap between research findings and practical application.

Main Methods:

  • A literature review focused on parent-targeted interventions for pediatric pain-related DGBIs.
  • Analysis of factors influencing the translation of research into practice.
  • Discussion of clinical application strategies.

Main Results:

  • Evidence supports parent-targeted interventions for pediatric DGBIs.
  • Implementation challenges include physician buy-in, parental engagement, and logistical factors.
  • Considerations for multiple caregivers, child age, and billing are important.

Conclusions:

  • Parent-targeted interventions for DGBIs have a growing evidence base.
  • Widespread adoption into clinical practice recommendations is limited.
  • Stakeholder engagement and attention to nuanced application are recommended for successful implementation.
Abstract

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
618
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
169
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
88
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
273
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127